⌕
Caris Life Sciences · CAI · Nasdaq
Tenet 40 · Weak
Compare
$21.00−8.85%At closeTenet 40 · Weak
$21.00−2.04 (−8.85%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Caris Life Sciences (CAI) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Zacks Investment ResearchNov 9, 2026 · 12:40 ET
BTSG vs. CAI: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Caris Life Sciences,?Inc. (CAI). But which of these two companies is the best option …

● Seeking AlphaNov 4, 2026 · 21:44 ET
Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript

Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript…

● MarketBeatNov 4, 2026 · 20:14 ET
Caris Life Sciences Q3 Earnings Call Highlights

Caris Life Sciences NASDAQ: CAI raised its full-year revenue outlook after third-quarter sales rose 27%, as growth in cancer-testing volumes accelerated for a second consecutive quarter. The company also reported lower q…

● Zacks Investment ResearchNov 4, 2026 · 18:51 ET
Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top Estimates

Caris Life Sciences,?Inc. (CAI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.08 per share a year ago.…

● PRNewsWireNov 4, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,000 total oncology tests Raises 2026 revenue guidance to $1.04 to …

● Zacks Investment ResearchOct 28, 2026 · 11:01 ET
Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out for

Caris Life Sciences,?Inc. (CAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

● PRNewsWireOct 19, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection

New campaign connects AI-powered performance insights linking advanced molecular intelligence to help detect cancer in earlier stages IRVING, Texas, Oct. 19, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a lea…

● PRNewsWireOct 15, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

IRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading TechBio company, today announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026. Caris Life …

● PRNewsWireOct 14, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026

Eight posters will feature AI-driven approaches to treatment prediction, risk stratification and biomarker discovery advancing precision medicine across multiple cancer types IRVING, Texas, Oct. 14, 2026 /PRNewswire/ -- …

● Defense WorldOct 8, 2026 · 07:07 ET
Caris Life Sciences, Inc. $CAI Shares Newly Bought by City Center Advisors LLC

City Center Advisors LLC acquired a new stake in Caris Life Sciences, Inc. (NASDAQ: CAI) during a recent quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 18,489 …

● Investors Business DailyOct 2, 2026 · 15:02 ET
IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months

Caris stock is pulling back after more than doubling in just two months. Wait for the IPO stock to offer a new buy point.…

● Seeking AlphaSep 17, 2026 · 10:35 ET
Caris Life Sciences: Diagnostics Growth With Room To Run

Caris Life Sciences has an already established profiling business that provides revenue and cash flows for its expanding diagnostics portfolio. CAI reuses molecular data and clinical relationships, leveraging them into n…

● Zacks Investment ResearchSep 16, 2026 · 04:56 ET
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?

Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.…

● PRNewsWireSep 8, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect

New partnership highlights the importance of finding cancer earlier through Caris Detect, a multi-cancer early detection blood test now available nationwide IRVING, Texas, Sept. 8, 2026 /PRNewswire/ -- Caris Life Science…

● PRNewsWireSep 2, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer

Seven studies will be presented, including two mini oral presentations and a poster tour presentation IRVING, Texas, Sept. 2, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today anno…

● Proactive InvestorsAug 27, 2026 · 10:59 ET
Caris Life Sciences study finds AI tool could guide pancreatic cancer treatment choice

Caris Life Sciences (Nasdaq:CAI), the Nasdaq-listed Techbio company, has published a study describing an artificial intelligence (AI) tool designed to help doctors choose first-line treatment for pancreatic cancer. The r…

● PRNewsWireAug 27, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels IRVING, Texas, Aug. 27, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: C…

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just CAI · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.